Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02088164

Enrollment

27741

Registered

2014-03-14

Start date

2012-02-29

Completion date

Unknown

Last updated

2014-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

PSA,, asian men,, survival

Brief summary

To determine the long-term survival outcome of subjects who had various PSA levels at screening

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

41 Years to No maximum

Healthy volunteers

Inclusion criteria

* Health men who received PSA screening at NTUH and CGMH

Exclusion criteria

* Prior history of prostate cancer

Design outcomes

Primary

Measure	Time frame
Diagnosis of prostate cancer	20 years (average)

Secondary

Measure	Time frame
Cancer-specific death	20 years (average)
Overall survival	20 years (average)

Countries

Taiwan

Outcome results